The Use of Blinatumomab in Patients With NGS-MRD Relapsed B-ALL After Autologous/Allogeneic Transplantation

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
The Use of Blinatumomab in Patients With NGS-MRD Relapsed B-ALL After Autologous/Allogeneic Transplantation	B-ALL	Not yet recruiting	Not applicable	2024-07-16		NCT06504186

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Institute of Hematology & Blood Diseases Hospital, China	285

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials